tiprankstipranks
Protara Therapeutics (TARA)
NASDAQ:TARA

Protara Therapeutics (TARA) Financial Statements

531 Followers

Protara Therapeutics Financial Overview

Protara Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.738; its P/E ratio is -0.56; Protara Therapeutics is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.74. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue--$ 4.00K-$ 17.00K
Gross Profit--$ 4.00K-$ 17.00K
EBIT$ -11.04M$ -9.86M$ -11.29M$ -9.04M$ -39.49M
EBITDA$ -10.93M$ -9.88M$ -11.01M$ -8.70M$ -38.97M
Net Income Common Stockholders$ -10.22M$ -9.86M$ -11.29M$ -9.04M$ -38.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 65.58M$ 74.03M$ 80.36M$ 86.61M$ 84.37M
Total Assets$ 78.95M$ 88.47M$ 95.14M$ 106.41M$ 113.29M
Total Debt$ 5.47M$ 5.70M$ 5.93M$ 6.16M$ 6.38M
Net Debt$ -60.11M$ -68.33M$ -74.43M$ -80.45M$ -77.99M
Total Liabilities$ 10.63M$ 11.51M$ 9.92M$ 11.64M$ 11.21M
Stockholders Equity$ 68.32M$ 76.96M$ 85.22M$ 94.77M$ 102.08M
Cash Flow-
Free Cash Flow$ -8.70M$ -6.60M$ -9.41M$ -12.89M$ -5.05M
Operating Cash Flow$ -8.70M$ -6.56M$ -9.41M$ -12.89M$ -5.04M
Investing Cash Flow$ 14.52M$ 6.38M$ 22.35M$ 9.86M$ -18.34M
Financing Cash Flow-$ -27.00K-$ -64.00K-
Currency in USD

Protara Therapeutics Earnings and Revenue History

Protara Therapeutics Debt to Assets

Protara Therapeutics Cash Flow

Protara Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis